Latest Health News
WHO Condemns Killing of 14 Health Workers in Southern Lebanon
The World Health Organization denounced the killing of 14 health workers in southern Lebanon over the past 24 hours amid ongoing conflict. This incident underscores the dangers faced by medical personnel in war zones. WHO called for the protection of health workers to ensure continued humanitarian aid.
Toxic Black Rain from Iran Oil Facility Strikes Poses Severe Health Risks
U.S.-Israeli airstrikes on Iranian oil facilities released toxic smoke forming 'black rain' with microscopic soot that lodges in lungs and enters bloodstreams, risking breathing issues, heart problems, and cancer. WHO and local officials urged staying indoors and wearing masks due to acidic rain causing skin burns and lung damage. Experts warn of acute effects like increased hospitalizations, especially for vulnerable groups.
Global Study Reveals 41% of Young Adults in Mind Health Crisis
A Sapien Labs report from 1 million people across 84 countries shows 41% of 18-34-year-olds face severe mental health issues impairing productivity, reversing trends from the early 2000s. Young adults are now four times more likely than those over 55 to suffer such challenges, worsened post-COVID. Recommendations include smartphone bans in schools and limits on social media and ultra-processed foods.
Breakthrough in Production of Chemotherapy Drug Doxorubicin
International researchers resolved molecular bottlenecks limiting natural production of doxorubicin, a key chemotherapy agent, after over 50 years. This advancement could improve access to the vital cancer treatment. The study highlights progress in biotech manufacturing for oncology drugs.
Prostate Cancer Screening Matches Breast Cancer Screening Effectiveness
New research at EAU26 Congress shows prostate cancer screening identifies significant cancers, reduces mortality, and minimizes harms comparably to breast cancer screening. Timing is critical for early diagnosis using advanced techniques. This supports broader implementation of prostate screening programs.
New CAR-T Cell Method Extends Fight Against Disease
Albert Einstein College of Medicine scientists developed a strategy to engineer CAR-T cells that persist longer in combating diseases. Announced on March 13, this could enhance immunotherapy efficacy. The approach shows promise for sustained cancer treatment.
Johnson & Johnson Reports Promising Results for Bladder Cancer Treatment
Phase 1 study of Erda-iDRS (TAR-210) in intermediate-risk non-muscle-invasive bladder cancer showed positive first-in-human outcomes. The intravesical therapy offers a novel approach. J&J highlighted its potential on March 13.
Accelerated Deep TMS Treats Depression in Six Days
Radial's landmark study published shows accelerated Deep Transcranial Magnetic Stimulation (TMS) can alleviate depression in six days versus months. This speeds up treatment for mental health patients. The research advances non-invasive brain stimulation therapies.
ImmunoBrain Presents Phase 1b Data for Alzheimer's Immunotherapy
ImmunoBrain will share topline Phase 1b results for its immune checkpoint treatment in Alzheimer's at AD/PD 2026. The therapy targets neurodegeneration via novel immunotherapies. Data from March 12 indicates clinical progress.
BioMarin Data Shows VOXZOGO Improves Proportionality in Achondroplasia Children
New studies at ACMG 2026 demonstrate early vosoritide (VOXZOGO) treatment enhances proportionality and arm span in children with achondroplasia. BioMarin presented positive impacts on March 12. This supports earlier intervention for the genetic condition.
Aspen Neuroscience Adopts Official Name for Parkinson's Cell Therapy
WHO adopted Sasineprocel as the nonproprietary name for Aspen's ANPD001, an investigational autologous cell therapy for Parkinson's disease. Announced March 12, this advances the clinical-stage therapy. It pioneers regenerative treatments for neurodegeneration.
Abbott Libre Tech Improves Glucose Management in Type 2 Diabetes
FreeDM2 trial results show Abbott's Libre technology helps Type 2 diabetes patients on basal insulin better manage glucose. Landmark study from March 12 highlights real-world benefits. This continuous glucose monitoring advances diabetes care.